(Q44374196)

2 December 2017

Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration (English)

1 reference

lysergic acid diethylamide

2 December 2017

0 references

1

Charles D Nichols

1 reference

2 December 2017

Efrain E Garcia

2

1 reference

PubMed ID

12654518

2 December 2017

Elaine Sanders-Bush

series ordinal

3

1 reference

2 December 2017

1 March 2003

1 reference

2 December 2017

Molecular Brain Research

1 reference

2 December 2017

111

1 reference

2 December 2017

1-2

1 reference

2 December 2017

182-188

1 reference

Visual Phenomenology of the LSD Flashback

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Serotonin, schizophrenia and antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Long-lasting alterations in behavior and brain neurochemistry following continuous low-level LSD administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Roles of nuclear factor kappaB in neuronal survival and plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Lysergamides of Isomeric 2,4-Dimethylazetidines Map the Binding Orientation of the Diethylamide Moiety in the Potent Hallucinogenic Agent N , N -Diethyllysergamide (LSD)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2803%2900029-9

7 January 2021

10.1016/S0169-328X(03)00029-9

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

12654518